May. 7 at 11:34 AM
$ALDX Okay, here’s the problem with ST as a DD resource. Our culture sort of dictates that for most participants that DD is not organic, ongoing for retail. That we just hear or see something, a narrative, an idea, a case and then we lock in. Join the club.
This poster has no followers to speak of.
He ran circles around Perceptive Advisors and others on this ticker. He has made all of his work public. His citizen’s petition arguably eased or illuminated the CRL path for FDA. He shared his work and his opinion freely BEFORE the CRL. He got ZERO likes on his post here. His posts on
$ALDX have been pure gold.
Suggestion. Learn “how to learn” about picking stocks. And if you find someone in bio who is this fluent in clinical trials. Follow them. 99% of us don’t understand the science and 50% of us busy telling each other how great the science is on some of these tickers. Think about that.
GL
PS Thank you @TripleGateCptl for generously putting your work into public domain at FDA, ST & X
